Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc., 64159 [2018-27039]

Download as PDF 64159 Federal Register / Vol. 83, No. 239 / Thursday, December 13, 2018 / Notices Dated: December 3, 2018. John J. Martin, Assistant Administrator. Cocaine ......................... Codeine ......................... Dihydrocodeine .............. Oxycodone .................... Hydromorphone ............. Ecgonine ........................ Hydrocodone ................. Morphine ........................ Thebaine ........................ [FR Doc. 2018–27036 Filed 12–12–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories ACTION: Drug code Controlled substance Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 11, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on November 22, 2017, Eli-Elsohly Laboratories, Mahmoud A. Elsohly Ph.D., 5 Industrial Park Drive, Oxford, Mississippi 38655 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: 9041 9050 9120 9143 9150 9180 9193 9300 9333 Schedule II II II II II II II II II The company plans to manufacture the listed controlled substances for product development and reference standards. In reference to drug codes 7360 (marihuana) and 7370 (THC), the company plans to isolate these controlled substances from procured 7350 (marihuana extract). In reference to drug code 7360 (marihuana), no cultivation activities are authorized for this registration. No other activities for these drug codes are authorized for this registration. Dated: December 3, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–27029 Filed 12–12–18; 8:45 am] connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on July 16, 2018, Cambrex High Point Inc., 4180 Mendenhall Oaks Parkway, High Point, North Carolina 27265 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substances Oxymorphone ................ Noroxymorphone ........... Drug code 9652 9668 Schedule II II The company plans to manufacture the above listed controlled substances in bulk for distribution to its customers. Dated: December 3, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–27039 Filed 12–12–18; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–09–P amozie on DSK3GDR082PROD with NOTICES1 SUPPLEMENTARY INFORMATION: Controlled substance Marihuana Extract ......... Marihuana ...................... Tetrahydrocannabinols .. Dihydromorphine ........... Amphetamine ................ Methamphetamine ......... VerDate Sep<11>2014 Drug code 7350 7360 7370 9145 1100 1105 17:12 Dec 12, 2018 Schedule I I I I II II Jkt 247001 DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc. ACTION: Notice of application. Frm 00063 Fmt 4703 Sfmt 4703 Importer of Controlled Substances Application: Noramco Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 14, 2019. Such persons may also file a written request for a hearing on the application on or before January 14, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 11, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in DATES: PO 00000 Drug Enforcement Administration E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 83, Number 239 (Thursday, December 13, 2018)]
[Notices]
[Page 64159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27039]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Cambrex 
High Point, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before February 11, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on July 
16, 2018, Cambrex High Point Inc., 4180 Mendenhall Oaks Parkway, High 
Point, North Carolina 27265 applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                                           Drug
         Controlled substances             code          Schedule
------------------------------------------------------------------------
Oxymorphone............................     9652  II
Noroxymorphone.........................     9668  II
------------------------------------------------------------------------

    The company plans to manufacture the above listed controlled 
substances in bulk for distribution to its customers.

    Dated: December 3, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-27039 Filed 12-12-18; 8:45 am]
 BILLING CODE 4410-09-P